The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4504194 5685046 I 4504194-9 20041103 20041117 EXP 2004-11-0005 IVAX RESEARCH, INC. 69 YR F N 20041103 MD

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4504194 1005397763 PS PACLITAXEL 1 INTRAVENOUS INTRAVENOUS Y D 75184
4504194 1005438470 C CARBOPLATIN 1

Indications of drugs used

Event ID DRUG SEQ INDI PT
4504194 1005397763 LUNG ADENOCARCINOMA

Outcome of event

Event ID OUTC COD
4504194 OT

Reactions reported

Event ID PT
4504194 CUTANEOUS LUPUS ERYTHEMATOSUS

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
4504194 HP
4504194 LIT

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4504194 1005397763 20030701